Chemoembolization with Vascular Disrupting Agent CKD-516 Dissolved in Ethiodized Oil in Combination with Doxorubicin: A  VX2 Tumor Model Study

Conclusions Treatment with a combination of CKD-516 and conventional transarterial chemoembolization showed therapeutic benefit in a liver tumor model.
Source: Journal of Vascular and Interventional Radiology - Category: Radiology Source Type: research